Cardiovascular Risk Prediction in Chronic Kidney Disease release_c6sbacy4x5gjzglwdbtz7apzfy

by xiejia li, Bengt Lindholm

Published in American Journal of Nephrology by S. Karger AG.

2022  

Abstract

As one of the main complications of chronic kidney disease (CKD), the incidence of cardiovascular disease (CVD) in CKD patients is high. CVD risk is markedly increased even at early stages of CKD, and CVD deaths account for half of all known causes of mortality in end-stage renal disease (ESRD) patients. The alarming rate of CVD in CKD patients demands accurate risk prediction to identify individuals at greater risk and therefore needing intensive surveillance and treatment in order to improve their prognosis. Since the CVD risk prediction models used in general population did not perform well in CKD patients, novel CVD risk biomarkers and improved risk predictive models adapted to CKD are receiving increasing attention in recent years. In this article, we review the applicability and performance of some of the available cardiovascular risk prediction tools in CKD.
In application/xml+jats format

Archived Files and Locations

application/pdf  1.7 MB
file_khsf23nxwrgxvgfdyu2gjn6ng4
www.karger.com (publisher)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2022-12-08
Language   en ?
DOI  10.1159/000528560
PubMed  36481730
Journal Metadata
Not in DOAJ
In Keepers Registry
ISSN-L:  0250-8095
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: ba5f2439-907c-40e0-98b0-705b84001798
API URL: JSON